Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2017
Total Assets: $171.80B
Liabilities Breakdown FY2017
Total Liabilities: $100.14B
Asset Breakdown
Total Assets: $171.80B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.34B | 0.8% |
| Accounts Receivable | $8.22B | 4.8% |
| Inventory | $7.58B | 4.4% |
| Property, Plant & Equipment | $13.87B | 8.1% |
| Goodwill | $55.95B | 32.6% |
| Intangible Assets | $48.74B | 28.4% |
| Other Assets | $36.10B | 21.0% |
Liabilities Breakdown
Total Liabilities: $100.14B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.66B | 4.6% |
| Long-Term Debt | $33.54B | 33.5% |
| Other Liabilities | $61.95B | 61.9% |